Candriam SCA’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-18,116
| Closed | -$1.71M | – | 892 |
|
|
2021
Q1 | $1.71M | Sell |
18,116
-1
| -0% | -$95 | 0.01% | 543 |
|
|
2020
Q4 | $1.78M | Buy |
18,117
+6,424
| +55% | +$632K | 0.01% | 555 |
|
|
2020
Q3 | $5.63M | Buy |
11,693
+5,154
| +79% | +$2.48M | 0.05% | 330 |
|
|
2020
Q2 | $5.07M | Buy |
+6,539
| New | +$5.07M | 0.05% | 331 |
|